共 50 条
- [1] Coagulation factor abnormalities related to discordance between anti-factor Xa and activated partial, thromboplastin time in patients supported with continuous-flow left ventricular assist devices [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2016, 35 (11): : 1311 - 1320
- [4] Anti-factor Xa Levels Versus Activated Partial Thromboplastin Time for Monitoring Unfractionated Heparin in Patients with Continuous Flow Left Ventricular Assist Devices [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2014, 33 (04): : S23 - S24
- [5] Anti-Factor Xa and Activated Partial Thromboplastin Time Strategies for Heparin Dosing After HeartMate3 Left Ventricular Assist Device Implantation [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2024, 43 (04): : S389 - S389
- [8] Anti-factor Xa activity, prothrombin time, and activated partial thromboplastin time in patients treated with factor Xa inhibitors [J]. Naunyn-Schmiedeberg's Archives of Pharmacology, 2023, 396 : 323 - 336
- [10] Factor Xa inhibitors in patients with continuous-flow left ventricular assist devices [J]. General Thoracic and Cardiovascular Surgery, 2020, 68 : 1278 - 1284